Reply letter to: Inhibition of SARS‐CoV‐2 replication using calcineurin inhibitors: Are concentrations required clinically achievable?

Gálvez‐Romero, J. L. ; Deveaux‐Homs, J. ; Real‐Ramírez, F. A. ; Palmeros‐Rojas, O. ; Pedraza‐Sánchez, S.

Journal of internal medicine, 2021-06, Vol.289 (6), p.928-929 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível